spacer
home > pmps > spring 2018 > time is short
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Time Is Short

Serialisation of prescription medicines will become mandatory in the EU on 9 February 2019, resulting in new labelling requirements as a prerequisite for market access. Other countries and regions are already further ahead. Therefore, pharmaceutical manufacturers must promptly invest in suitable solutions. Simultaneously, late-stage customisation is becoming increasingly important due to continuously decreasing batch sizes. If both digital printing processes can be combined in one step, the opportunity to implement compliant and costoptimised production will arise.

The first logical step is considering where serialisation can most sensibly be performed in the production process. Is it:

  • During the offset printing of sheets for the later folding cartons?
  • In a contract packaging facility?
  • In special logistics centres?
  • In the packaging lines of pharma manufacturers?

The solution chosen by the company will depend on the existing infrastructure as well as several other factors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Stefan Rowinski, Product Manager at Atlantic Zeiserís pharma and packaging solutions division, specialises in the development and marketing of system solutions for serialisation, late-stage customisation, and track-and-trace applications. Additionally, his expertise includes a deep knowledge of processes and workflow in sensitive environments and data management solutions. Prior to his position as a product manager, Stefan spent years designing, implementing and planning one-stop solutions for product individualisation and headed the projects to implement these solutions. 
spacer
Stefan Rowinski
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

FlyPharma

FlyPharma Conferences and Pharma.Aero are joining together to support a collaborative platform for forward-thinking pharma and cargo professionals at this yearís FlyPharma Conference Europe, with a view to discussing key pharma supply chain challenges affecting all stakeholders.
More info >>

White Papers

Recommendations for Implementing Assessment Criteria Guidelines in Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

Perceptive Informatics

Standardized assessment criteria are becoming increasingly important in obtaining valid outcomes in oncology clinical trials. While standardized criteria encourage a more uniform approach to assessing clinical trial data, they are often subject to the interpretation of the user. These differences in interpretation, while seemingly minor, can have a major impact on assessments. The most commonly used standardized criteria for lymphoma have been no exception. Differences such as minimum new lesion size, lymph node normalization size requirements, inclusion of extranodal lesions and assessment of organomegaly can have a profound effect on overall response. Additionally, heightened scrutiny of the assessment criteria used in a given protocol can lead to questions about a drugís efficacy if not applied correctly according to regulatorsí interpretation.
More info >>

 
Industry Events

PPMA SHOW 2018

25-27 September 2018, NEC, Birmingham, UK

The UKís leading production line event is celebrating its 30th Anniversary. Taking place at the NEC, Birmingham from 25-27 September 2018, the exhibition showcases the latest processing and packaging machinery. Attended by thousands of manufacturers of food, pharmaceuticals and FMCG as well as contract packers and more.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement